Premium
Mobile health ( mHealth ) based medication adherence measurement – a pilot trial using electronic blisters in diabetes patients
Author(s) -
Brath Helmut,
Morak Jürgen,
Kästenbauer Thomas,
ModreOsprian Robert,
StrohnerKästenbauer Hermine,
Schwarz Mark,
Kort Willem,
Schreier Günter
Publication year - 2013
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.12184
Subject(s) - medicine , mhealth , diabetes mellitus , crossover study , regimen , blood pressure , randomized controlled trial , type 2 diabetes , physical therapy , alternative medicine , psychological intervention , nursing , endocrinology , pathology , placebo
Aims The aim of the present study was to evaluate a mobile health ( mHealth ) based remote medication adherence measurement system ( mAMS ) in elderly patients with increased cardiovascular risk treated for diabetes, high cholesterol and hypertension. Cardiovascular risk was defined as the presence of at least two out of the three risk factors: type 2 diabetes, hypercholesterolaemia and hypertension. Methods For treatment of diabetes, hypercholesterolaemia and hypertension, four predefined routinely used drugs were selected. Drug adherence was investigated in a controlled randomized doctor blinded study with crossover design. The mAMS was used to measure and improve objectively the adherence by means of closed‐loop interactions. Results The mean age of the 53 patients (30 female) was 69.4 ± 4.8 years. A total of 1654 electronic blisters were handed out. A statistically significant difference ( P = 0.04) between the monitoring and the control phase was observed for the diabetes medication only. In a post‐study questionnaire twenty‐nine patients appreciated that their physician knew if and when they had taken their medications and 13 asked for more or automated communication with their physicians. Only one subject withdrew from the study because of technical complexity. Conclusions The results indicate that mHealth based adherence management is feasible and well accepted by patients with increased cardiovascular risk. It may help to increase adherence, even in patients with high baseline adherence and, subsequently, lead to improved control of indicators including blood pressure and cholesterol concentrations. Electronic blisters can be used in a multi‐medication regimen but need to be carefully designed for day‐to‐day application.